Deadly Crestor Side Effects Subject of New Lawsuit
On July 23, 2012, a Crestor lawyer filed a personal injury lawsuit against AstraZeneca Pharmaceuticals and McKesson Corporation on behalf of nineteen plaintiffs in the Superior Court of the State of California in Los Angeles County. According to court documents, the plaintiffs allegedly suffered from serious injuries including myocardial infarction, cardiomyopathy, and type 2 diabetes as a direct result of using Crestor. Multiple Crestor lawsuits recently filed in court have alleged that the defendants engaged in tortious conduct that compromised the health and safety of patients.
The FDA granted AstraZeneca approval to market Crestor as a prescription drug for the treatment of high cholesterol in 2003. On February 28, 2012, the FDA issued a safety communication to inform the public about important changes to Crestor warning label. The updated label notes that patients on the medication are at increased risk for developing liver damage, memory loss, and elevate blood sugar levels.
Crestor lawsuits allege dangerous side effects
Clinical studies raised questions regarding the safety of patients who used Crestor. The research revealed that patients were at greater risk of suffering from heart-related illnesses such as heart attack, heart muscle deterioration, congestive heart failure, and sudden cardiac death. Additional side effects of Crestor include kidney and liver damage, muscle deterioration, and the onset of type 2 diabetes.
The plaintiffs in this California lawsuit claim to have suffered from many of the complications linked to patients in the clinical studies. All began taking Crestor upon the recommendation of their respective physicians. Some of the injuries they sustained are heart attack, weakening of the heart muscle, congestive heart failure, development of diabetes and rapid deterioration of skeletal muscle. The joint complaint alleges that the plaintiffs’ injuries are a direct result of using Crestor. The lawsuit also states that the plaintiffs had difficulty realizing the relationship between their injuries and the cholesterol-lowering drug since the defendants allegedly concealed the side effects of Crestor from the FDA and the public.
Plaintiffs accuse drug maker of fraudulent concealment
The lawsuit further claims that the defendants engaged in negligence and fraudulent concealment. AstraZeneca is accused of selling and distributing a prescription drug in California that they knew was defective, unreasonably dangerous and likely to cause harm to the patients who used it. The complaint also states that the defendants suppressed the publication of results from clinical studies which concluded that a hazardous relationship existed between Crestor and certain medical conditions.
The plaintiffs accuse the defendants of using false or misleading statements in their advertisements and promotional materials, and say that the defendants failed to warn the public, physicians or patients about the adverse side effects of using Crestor. The general public and medical community justifiably relied on the information provided by the defendants. As detailed in the complaint, the plaintiffs contend that had they known about the dangerous side effects, they wouldn’t have used the prescription drug and would have chosen alternative treatments that were effective and safer. The claimants are seeking compensation for their economic and non-economic losses based on evidence presented during their trial.
Crestor lawsuits continue to accumulate in California state court as more patients allege that the drug directly caused them to sustain serious injuries.
- Crestor side effects, Mayo Clinic. Retrieved from http://www.mayoclinic.com/health/drug-information/DR601223/DSECTION=side-effects
- Tennessee to receive more than $1.5 million from landmark multistate agreement with Astrazeneca Pharmaceuticals. Retrieved from http://www.tn.gov/attorneygeneral/press/2011/pr11-05.pdf